Healthcare organizations often struggle to provide quality care with growing volumes of patient information, and big data initiatives may be the solution to an accurate, real-time analytic approach to treatment.
Healthcare IT News reported that medical professionals are gradually advocating the advantages to big data initiatives, which aid providers in taking large sets of information collected over a patient's lifetime and processing it for enhanced value. According to the source, Gregory Veltri, CIO of Denver Health and Ph.D. Mical DeBrow co-presented at the 2013 HIMSS Annual Convention & Exhibition on how organizations need to shift their entire data management approach in order to benefit from big data. According to the news source, Veltri explained that effective management of information requires that organizations define objectives, collect and store all desired data, analyze and measure the information against proven standards and benchmarks, and then make that data actionable for tangible results.
Healthcare IT News revealed that DeBrow believes predictive analytics will become a key function of turning knowledge into action. Further, Veltri described the big data process as creating "one source of truth." By unifying and centrally analyzing information through dba services, data becomes more comprehensive, consistent and accurate.
Data support improves accuracy
In an interview with Medical Marketing & Media, vice president of real-world evidence solutions for IMS Health, Jon Resnick, explained that meeting new demands for these analytic efficiencies has forced organizations to boost support for a big data infrastructure.
"If there is this foundation of information that can be created into an evidence base, it can allow for greater efficiency and value," he told the source.
Medical Marketing & Media reported that Humana and Pfizer formed a partnership aimed at using big data to monitor chronic conditions to improve healthcare for the elderly. Steve Chick, vice president of Humana, explained to the source that real-world data is used to examine patient behaviors and measure that information against other variables to ensure that the right medicine is administered. Marc Berger, vice president of Pfizer, further revealed that real-world analytics can support existing trial data by providing insight into trends and patterns in therapy outcomes.
Resnick hopes that more organizations will be leveraging big data technologies to fuel new, evidence-based discussions on curing various diseases. Additionally, he told the source that these analytics can allow pharma to devise more valuable contracts and regulators to better enforce security.
Mining the explosion of patient data will continue to allow providers to gain a deeper understanding of how to continually improve care for more successful treatment.
RDX's business intelligence and big data experts assist customers in leveraging data contained in large data stores. For more information, please visit our Business Intelligence and Predictive Analytics pages or contact us.